San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 and $16.00 per share. The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB.